Latest News - Veeva Systems
Top Corporates Hub
Veeva Systems
Veeva Systems: Competition Intensifying, Shares Remain Overvalued
06.09.2025 02:41
Veeva Systems leads in life sciences cloud software with strong growth and margins, but faces valuation concerns. Learn why VEEV stock is a hold.
Veeva Systems Inc. (VEEV): A Bull Case Theory
05.09.2025 16:31
We came across a bullish thesis on Veeva Systems Inc. on Compounding Your Wealth’s Substack by Sergey. In this article, we will summarize the bulls’ thesis on VEEV. Veeva Systems Inc.’s share was trading at $269.20 as of August 29th. VEEV’s trailing and forward P/E were 55.39 and 35.7 respectively according to Yahoo Finance. Veeva Systems (VEEV) […]
2 Growth Stocks to Buy and Hold for the Next Decade
05.09.2025 15:06
These companies check many of the boxes that long-term market leaders typically do.
Veeva Q2: Outpacing Salesforce's "Kill" Switch
05.09.2025 10:52
Salesforceâs commentary on âkilling Veevaâ is highly exaggerated, as Veevaâs strength lies in building deep industry applications. Read the latest stock analysis here.
Is Trending Stock Veeva Systems Inc. (VEEV) a Buy Now?
03.09.2025 14:00
Zacks.com users have recently been watching Veeva (VEEV) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
The Top 5 Analyst Questions From Veeva Systems’s Q2 Earnings Call
03.09.2025 06:31
Veeva Systems’ second quarter results drew a negative market reaction despite the company beating Wall Street’s expectations on revenue and non-GAAP profit. Management attributed the quarter’s performance to strong execution across its R&D and commercial product lines, including continued momentum in Crossix and Vault CRM. CEO Peter Gassner highlighted the resolution of the long-standing dispute with IQVIA as a major step forward, stating, “We can begin to learn about each other and partner for
Veeva Systems: Overall, A Good Q2, With Only A Few Minor Issues
28.08.2025 09:43
Veeva Systems shines with strong Q2 results, robust growth, and a new partnership with IQVIA. Click here to read my most recent analysis of VEEV stock.
Veeva Systems Inc. (VEEV) Q2 2026 Earnings Call Transcript
28.08.2025 01:34
Veeva Systems Inc. (NYSE:VEEV) Q2 2026 Earnings Conference Call August 27, 2025 5:00 PM ETCompany ParticipantsBrian Van Wagener - Chief Financial...
What To Expect From Veeva Systems’s (VEEV) Q2 Earnings
26.08.2025 03:02
Life sciences cloud software provider Veeva Systems (NYSE:VEEV) will be reporting results this Wednesday after market close. Here’s what you need to know.
Nvidia Stock Pauses Ahead Of Key Earnings Report; Will Results From Veeva Systems Impress Again?
22.08.2025 14:21
Nvidia stock is below its 21-day line, but it's still near highs ahead of another important earnings report.
Seeking Clues to Veeva (VEEV) Q2 Earnings? A Peek Into Wall Street Projections for Key Metrics
22.08.2025 13:15
Evaluate the expected performance of Veeva (VEEV) for the quarter ended July 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
Veeva Systems Inc. (VEEV) is Attracting Investor Attention: Here is What You Should Know
20.08.2025 13:00
Veeva (VEEV) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Research Shows Medtechs Prioritizing Site Collaboration and Data Quality
12.08.2025 11:03
Veeva Systems (NYSE: VEEV) today announced findings from the 2025 Veeva MedTech Clinical Benchmark, showing that medtech clinical teams are focused on streamlining work with research sites to reduce manual processes (68%), improve study quality (56%), and gain greater visibility and oversight (55%). The findings emphasize an opportunity to leverage technology to simplify and standardize clinical workflows, work more effectively with sites, and speed trials.
2 Reasons to Watch VEEV and 1 to Stay Cautious
11.08.2025 04:04
Veeva Systems has had an impressive run over the past six months as its shares have beaten the S&P 500 by 15.1%. The stock now trades at $282.13, marking a 20.4% gain. This was partly thanks to its solid quarterly results, and the run-up might have investors contemplating their next move.
1 Cash-Heavy Stock on Our Watchlist and 2 We Find Risky
04.08.2025 04:34
Companies with more cash than debt can be financially resilient, but that doesn’t mean they’re all strong investments. Some lack leverage because they struggle to grow or generate consistent profits, making them unattractive borrowers.
AI Stock With Unique Focus Joins Palantir, Nvidia On 3 Elite Lists
30.07.2025 12:00
As top funds bet big on AI stocks Nvidia and Palantir, they also scooped up Veeva stock as it teases a breakout.
Survey Finds Medtechs Lack Confidence in Regulatory Data Quality
30.07.2025 11:03
Veeva Systems (NYSE: VEEV) today announced findings from the 2025 Veeva Medtech Regulatory Affairs Benchmark, revealing that 50% of respondents lack full confidence in the completeness of their underlying data for global product registrations. Many organizations are manually reconciling data to ensure regulatory compliance, increasing the administrative burden for regulatory affairs teams.
Dow Jones Futures Rise; S&P 500 Hits High As Google Lifts AI Giants, Tesla Plunges
25.07.2025 11:16
The stock market was mixed as Google lifted AI giants and Tesla dived. President Trump and Federal Reserve Chairman Jerome Powell disagreed.
Veeva (VEEV) Expands with Astellas and Sarah Cannon in Global CRM and Oncology Trials
15.07.2025 04:54
Veeva Systems Inc. (NYSE:VEEV) ranks among the best cloud stocks to buy according to Wall Street analysts. Veeva Systems Inc. (NYSE:VEEV) appears to be expanding its network this year in the form of high-impact partnerships. In June, the company declared that pharmaceutical giant Astellas would adopt Veeva Vault CRM as the industry standard for commercial […]
CLOU: A Strategic Positioning Benefiting From AI
15.07.2025 03:22
Global X Cloud Computing ETF offers niche exposure to pure-play cloud computing. Click here to read more about CLOU and why it is a Buy.